Overview
- Description
The company is in Phase 2 clinical trials with their innovative anti-inflammatory macrolide-derived molecules, targeting COPD and other respiratory diseases.
- Website
- Country
- Iceland
- Sector
- Health Biotechnology
Engage with EpiEndo Pharmaceuticals*
*By clicking here you will be leaving the official EIC website and you will be directed to the Dealroom.co domain, an official EISMEA contractor for the EIC investor matchmaking platform.